HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Clinical trials for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA) trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis study tests a new treatment called GT719 for adults with certain blood cancers (B-cell lymphoma or leukemia) that have come back or not responded to standard therapy. The treatment uses specially engineered immune cells to target and attack cancer cells. The trial will enrol…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: PHASE1, PHASE2 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New 'Off-the-Shelf' cell therapy takes on tough blood cancers
Disease control Recruiting nowThis early-stage study tests a new treatment called GT719 for adults with certain blood cancers (B-cell lymphoma or leukemia) that have come back or not responded to standard therapy. The treatment uses specially engineered immune cells that are made from a healthy donor, so they…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 26, 2026 11:59 UTC
-
Experimental shot tackles tough blood cancers and anemia
Disease control Recruiting nowThis early-stage study tests a new treatment called GT801 in 28 adults with certain blood cancers (like leukemia and lymphoma) or an autoimmune blood disorder (AIHA) that have not responded to standard therapies. The goal is to see if the treatment is safe and can shrink tumors o…
Matched conditions: HEMATOLOGICAL MALIGNANCY (LEUKEMIA- LYMPHOMA)
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 22, 2026 13:52 UTC